Last $3.68 USD
Change Today +0.10 / 2.79%
Volume 1.6M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 11:32 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

J. Scott Garland

Chief Commercial Officer and Executive Vice President, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

45$1,358,652
As of Fiscal Year 2013

Background*

Mr. J. Scott Garland has been Executive Vice President and Chief Commercial Officer at Exelixis, Inc. since October 25, 2011. Mr. Garland oversees the commercial functions of marketing, sales and commercial operations, and collaborate closely with Exelixis' development and manufacturing teams to provide commercial perspective for cabozantinib development efforts across multiple oncology indications. Mr. Garland is a seasoned biotechnology and pharmaceutical industry ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Duke University
Bachelor's Degree
California State Polytechnic University, Pomona

Other Affiliations*

Annual Compensation*

Salary$396,218
Bonus$181,084
Total Annual Compensation$577,302

Stock Options*

All Other Compensation$7,650
Exercisable Options146,770
Exercisable Options Value$64,247
Unexercisable Options326,230
Unexercisable Options Value$136,878
Total Value of Options$273,875
Total Number of Options655,000

Total Compensation*

Total Annual Cash Compensation$584,952
Total Short Term Compensation$577,302
Other Long Term Compensation$7,650
Total Calculated Compensation$1,358,652
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $3.68 USD +0.095

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.